Two commercial feedlot experiments were conducted to compare performance and carcass characteristics of feedlot heifers and steers using 2 implant strategies. In Exp. 1, heifers (n = 1,124; initial BW = 279 ± 5 kg) 
slaughter. In Exp. 2, steers (n = 1, 066;  initial BW = 269 ± 2 kg) were administered either or 20 mg estradiol benzoate and 200 mg progesterone) at initial processing, with both treatment groups receiving Synovex-H. In addition, Revalor-IH implanted 
as a common terminal implant an average of 78 d (range 71 to 84 d) before slaughter. Implanting heifers initially with Revalor-IH improved G:F (P = 0.01) and ADG (P = 0.05) compared with heifers implanted initially with

INTRODUCTION
Growth-promoting implants have been proven as safe and effective management tools in feedlot cattle production. Implants increase growth rate, improve feed conversion, and increase final BW of cattle by as much as 14 to 42 kg compared with nonimplanted cattle (Guiroy et al., 2002) . These improvements in growth are largely the result of increased muscle deposition (NRC, 1996) . This increase in growth rate and lean deposition may occur at the expense of carcass quality (i.e., reduction in marbling score) if implanted cattle are marketed at weights comparable with nonimplanted cattle, which suggests that to achieve comparable QG, implanted cattle should be fed to greater BW and similar body composition (Preston et al., 1990; Guiroy et al., 2002) .
Determining proper implant strategy (number of days exposed and dosage, or combination of dosages) is an important consideration relative to QG. Several commercial anabolic implants are available to optimize carcass value (Montgomery et al., 2001) . These implants contain a single dose or a combination dose of compounds. Different responses to implants have been attributed to the total amount of an anabolic agent (Bartle et al., 1992) . Moderate-dose initial implant combinations of estradiol-17β (E2) and trenbolone acetate (TA) are available for heifers and steers and may have different effects on animal performance and carcass quality when compared with estrogen-based initial implants. Hutcheson et al. (2003) observed that a combination of E2 and TA implants, used in either the full or reduced dosage form, improved ADG, G:F, and hot carcass weight (HCW) while maintaining carcass quality in short-fed yearling steers when compared with an estrogen-based implant.
The objective of the present study was to evaluate the effects of 2 moderate-dose implants (Revalor-IH and Revalor-IS; Intervet/Schering Plough Animal Health, DeSoto, KS) relative to estrogen-based initial implants on animal performance and carcass characteristics of feedlot heifers and steers.
MATERIALS AND METHODS
Experiment 1
Beef heifers (British cross; initial BW = 279 ± 5 kg) were received at a commercial feedlot in central Nebraska and at initial processing were allotted randomly to 1 of 2 implant regimens (within 72 h after arrival). Each group of incoming cattle represented a treatment replication, for a total of 6 replications per treatment (12 pens total; 1,124 heifers). Heifers were kept separate by arrival date and assigned randomly to pens by sorting every other animal as it exited the processing chute during initial processing. Within a replication, all heifers were from the same source and arrived at the feedlot at the same time. At initial processing, heifers were individually weighed, vaccinated with Bovishield 4 (Pfizer Animal Health; New York, NY), treated for internal and external parasites with Dectomax (Pfizer Animal Health), palpated for previous ear implants (implants were removed if present), and given a lot tag for pen identification and individual animal identification number. Initial implant treatment was either Revalor-IH (8 mg E2 and 80 mg TA; Intervet/Schering Plough Animal Health) or Synovex-H (20 mg estradiol benzoate, 200 mg testosterone propionate; Fort Dodge Animal Health, Overland Park, KS). After processing, pens of heifers were weighed on a group scale just before being moved into their home pen. The pen BW was used as the initial BW for performance calculations. The total number of animals in a pen ranged from 80 to 120 head, and was equal within replicates. After arrival and processing, one complete replicate was removed from the study because of excessive morbidity.
Heifers were fed a common steamflaked, corn-based finishing diet twice daily throughout the study (Table 1) . Cattle were adapted to the finishing diet over an 18-to 21-d step-up period beginning with 45% roughage that was progressively replaced with corn. The finishing diet also provided 0.4 mg/heifer daily of melengesterol acetate (MGA; Pfizer Animal Health), 33 g/ton Rumensin (monensin; Elanco Animal Health, Greenfield, IN), and 11 g/t Tylan (tylosin; Elanco Animal Health), all on a 100% DM basis.
All heifers were reimplanted with Revalor-200 (20 mg E2 and 200 mg TA) as the common terminal implant 81 d (range 69 to 85 d) before slaughter. At reimplantation time, heifers were removed from their pens and immediately weighed on a group scale to obtain a pen BW. Heifers were then revaccinated with Bovishield 4 (Pfizer Animal Health), individually weighed, and reimplanted before being sent back to their home pen for the remainder of the feeding period. Initial implants also were evaluated at this time to identify defects, including abscessed, bunched, missing, crushed, partial, or cartilage-placed implants. Heifers were fed an average of 177 d (range 147 to 202 d). All pens within a replication were marketed on the same day under identical conditions at the same commercial abattoir (Tyson Fresh Meats Inc., Lexington, NE). Hot carcass weights were recorded on the day of harvest. Carcass 12th-rib fat thickness, LM area, and USDA called QG and YG were recorded
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Experiment 2
Beef steers (British cross; initial BW = 269 ± 2 kg) were received as in Exp. 1, resulting in 6 replications per treatment (1,077 steers). At initial processing, steers were individually weighed, vaccinated with Titanium 5 (Intervet/Schering Plough Animal Health), treated for internal and external parasites with Dectomax (Pfizer Animal Health), palpated for previous ear implants (implants were removed if present), and given a tag for individual and pen identification. Initial implant treatment was either lication were marketed on a common day under identical conditions at the same commercial abattoir (National Beef Packing, Dodge City, KS). In Exp. 2, carcass data were collected in a manner similar to that described in Exp. 1. Animal performance and carcass data were analyzed using the MIXED procedure of SAS (SAS Institute Inc., Cary, NC) for a randomized complete block design, where pen served as the experimental unit. Chi-square distribution analysis was used for QG and YG data. The fixed model effect included the initial implant treatment, and replication of cattle was termed a blocking factor and placed into the random statement. Least squares means were separated using the PDIFF statement of SAS.
RESULTS AND DISCUSSION
All data are presented with dead animals and railers (cattle that are sold prior to being finished because of illness or an injury) removed from the analysis. As a result, in Exp. 1, 28 and 15 heifers were removed from the Revalor-IH and Synovex-H treatments, respectively. In Exp. 2, 15 and 13 steers were removed from the Revalor-IS and Synovex-S treatments, respectively. Feed intake was calculated from feedlot close-out information on each individual pen of cattle. Defects in the initial implants (Exp. 1), as determined at the time of reimplantation, are summarized in Table 2 . Initial implants were checked for determination of abscessed, missing, crushed, or cartilage placed implants (Table 2) . Only 1.6% of heifers administered Revalor-IH and 2.2% of heifers administered Synovex-H were found to have implants that fell within these criteria. In Exp. 2, only 1 animal in the Revalor-IS and 3 animals in the Synovex-S treatments possessed abscessed implants. Additionally, only 13 animals in the Revalor-IS and 15 in the Synovex-S treatment had identifiable defects in the initial implant. Therefore, 2.5% of steers administered Revalor-IS and 2.8% of steers administered Synovex-S were found to have implants that fell within the defective criteria.
Heifer performance is presented in Table 3 and is expressed on a live performance basis and on a carcassadjusted basis using a common dressing percentage (63%). Dry matter intake was similar between treatments (P = 0.63). On a carcass-adjusted basis, heifers implanted initially with Revalor-IH tended (P = 0.10) to have greater ADG and greater G:F (P = 0.03) compared with heifers given Synovex-H. Likewise, on a live basis, heifers implanted initially with Revalor-IH tended (P = 0.05) to gain faster and had increased G:F (P = 0.01). Revalor-IH-implanted heifers tended to have heavier (P = 0.15) HCW but similar dressing percentage, 12th-rib fat thickness, and LM area when compared with Synovex-H-implanted heifers (Table 4) . Calculated empty body fat and USDA called YG were similar between treatments, indicating that heifers were fed to similar body fat end points. Calculated YG tended (P = 0.09) to be higher for heifers implanted with Revalor-IH (2.71 vs. 2.60 for Revalor-IH and Synovex-H, respectively) as a result of heavier HCW used in the calculation. Total carcasses grading Choice were not different between initial implant treatments. However, heifers administered Revalor-IH had greater (P = 0.07) marbling scores, with 58% more carcasses (P = 0.02) achieving the up-
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Initial implant strategies for finishing cattle per two-thirds category of Choice QG (Table 4) . Feedlot performance of steers (Exp. 2) is presented in Table 5 and is expressed on a live and carcass-adjusted basis using a common dressing percentage (63%). Dry matter intake was similar between treatments. Steers implanted initially with Revalor-IS had 3.6 kg greater (P = 0.07) carcass-adjusted final BW compared with steers initially implanted with Synovex-S. Although implanting steers initially with Revalor-IS improved G:F by 2% in the live category and 2.5% in the carcass-adjusted calculation, neither difference was significantly different from the Synovex-S treatment (P = 0.30 and 0.23, respectively). Similarly, live ADG (P = 0.31) and carcassadjusted ADG (P = 0.22) were not different between implant treatments.
Carcass characteristics for Exp. 2 are shown in Table 6 . Steers implanted with Revalor-IS had 2.3 kg heavier (P = 0.07) HCW but similar dressing percentage, 12th-rib fat thickness, calculated empty body fat, and LM area when compared with steers implanted with Synovex-S. The USDA called YG and calculated YG were similar between treatments, indicating that steers were fed to a similar compositional end point. Marbling scores, carcasses grading upper two-thirds Choice, and total carcasses grading Choice were not different between initial implant treatments. Yield grade breakdowns are also presented in Table 6 . There were no differences between treatments when analyzed in single numerical categories or when combined, as was illustrated when YG 1 and 2 were combined.
Although the anabolic response of ruminants to exogenous androgens and estrogens is still not thoroughly understood, it has been well established that growth promotants increase the rate of protein deposition in feedlot cattle by stimulating skeletal muscle growth. Cattle given combinations of TA and E2 have been observed to gain faster compared with cattle that are given E2 or TA alone (Bartle et al., 1992; Johnson et al., 1996) . Typically, cattle are initially implanted with an estrogen-based implant at the beginning of the feeding period and then reimplanted with an E2-TA combination implant.
Revalor-IS and Revalor-IH are considered mild combination implants (Montgomery et al., 2001) . Limited data are available comparing these relatively new mild combination initial E2-TA implants with estrogenbased initial implants. Data from Hutcheson et al. (2003) suggest that a single implant of a combination of E2 and TA, used in either the full or reduced-dosage form, increased ADG, G:F, and HCW while maintaining carcass quality in short-fed yearling steers when compared with an estrogen-based, single implant program.
Data from Exp. 1 provide evidence that Revalor-IH as an initial implant for feedlot heifers leads to equal or better performance when compared with estrogen-based initial implants (Synovex-H) and improves marbling and carcasses grading high Choice. The primary difference in hormone composition of the 2 initial implant treatments is the presence of 80 mg TA in the Revalor-IH, but another notable difference is the lower E2 content of Revalor-IH compared with Synovex-H (8 vs. 14.4 mg). In heifers, MGA prevents ovulation and increases estrogenic secretion by persistent follicles (Bloss et al., 1966) . Therefore, only part of the exogenous estrogen from the initial implants was needed to stimulate skeletal muscle growth and improve G:F. This suggests that differences in response between initial implant treatments for feedlot heifers may be due to the effects of TA.
Data from Exp. 2 illustrate similar effects on performance or carcass characteristics when implanting steers initially with Revalor-IS or Synovex-S. However, Revalor-IS tended to improve HCW and carcass-adjusted final BW compared with steers implanted initially with Synovex-S. Hutcheson and Larson (2005) evaluated the performance of 2,578 beef feedlot steers in 2 large pen trials with the same experimental design used in the present study. Steers were initially implanted with Synovex-S and Revalor-IS and reimplanted with Revalor-S on approximately d 80. No differences were detected between initial implants for performance and carcass characteristics. Hutcheson and Larson (2005) observed that either Synovex-S or Revalor-IS, when used as an initial implant in a reimplantation program, would result in similar feedlot performance and carcass characteristics of yearling steers. These results are in agreement with data from the present study and suggest that initial implant programs using mild combinations will have no negative effects on performance or carcass characteristics of finishing steers. These data suggest that reduceddose combinations of E2 and TA can be used effectively as initial implants for feedlot cattle. No negative effects of these implants on performance or carcass characteristics of finished cattle were observed. In addition, these experiments demonstrate a significant increase in feed efficiency and carcass quality in finishing heifers and a possible increase in carcass weight in finishing steers when moderate-dose E2-TA implants replace estrogenbased initial implants. 
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